← All patents

US12319744B2

Treatment and prevention of hemophilic arthropathy with an antibody against …

University of Texas System

Abstract

An antibody, preferably a blocking antibody, and most preferably a monoclonal antibody (mAb), specific for human endothelial cell protein C receptor (EPCR) such as mAbs JRK 1494 or JRK 1535 is used to reduce or attenuate joint swelling, macrophage infiltration, iron deposition and/or blood vessel …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Vijaya M. LELLA
Priority date
September 06, 2018
Filing date
September 05, 2019
Grant date
June 03, 2025
Publication date
June 03, 2025
Language
en
Metadata fetched
August 29, 2026 00:33